Odds of COVID-19 Mortality Lower for Women Receiving HRT
MONDAY, May 23, 2022 (HealthDay News) -- Hormone replacement therapy (HRT) use is associated with reduced odds of all-cause mortality among women with a recorded diagnosis of COVID-19, according to a study published online May 17 in Family Practice.
Hajira Dambha-Miller, M.R.C.G.P., Ph.D., from the University of Southampton in the United Kingdom, and colleagues conducted a retrospective cohort study to examine the association between HRT or combined oral contraceptive pill (COCP) use and the likelihood of death among women with COVID-19. A cohort of 1,863,478 women older than 18 years of age from 465 general practices in England was identified.
The researchers identified 5,451 COVID-19 cases within the cohort. During the follow-up period (mean, 164.9 days), 12.2 percent of women died. HRT was associated with a reduction in all-cause mortality in COVID-19 (adjusted odds ratio, 0.22). In women prescribed COCPs, there were no reported events for all-cause mortality, preventing further examination of the impact of COCPs.
"We found that HRT prescription within six months of a recorded diagnosis of COVID-19 infection was associated with a reduction in all-cause mortality," the authors write. "From these results, women should be reassured that there is no indication to discontinue HRT use because of the pandemic."
Related Posts
It Doesn’t Take Much Weight Gain to Raise Odds for Knee Trouble
WEDNESDAY, Oct. 19, 2022 (HealthDay News) -- A person doesn’t have to pack on...
La robótica lleva el bastón blanco al siglo XXI
JUEVES, 16 de septiembre de 2021 (HealthDay News) -- El "bastón blanco" del que...
Hepatitis C and Clinical Trials
What are clinical trials?Clinical trials are the means by which new drugs and...
Las citas para pruebas de detección y salud preventiva para la mujer que usted necesita
VIERNES, 19 de mayo de 2023 (HealthDay News) -- Las citas para pruebas de...